SI1941026T1 - Postopki za proizvodnjo beljakovin z uporabo protisenescenčnih spojin - Google Patents

Postopki za proizvodnjo beljakovin z uporabo protisenescenčnih spojin

Info

Publication number: SI1941026T1
Authority: SI; Slovenia
Prior art keywords: methods; protein production; senescence compounds; senescence; compounds
Prior art date: 2005-10-24

Application number

SI200631796T

Other languages

English (en)

Inventor

Yen-Tung Luan

Wenge Wang

Paul Thoday

Denis Drapeau

Judy Chou

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-24

Filing date

2006-10-24

Publication date

2014-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37873105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1941026(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-24 Application filed by Wyeth Llc filed Critical Wyeth Llc

2014-07-31 Publication of SI1941026T1 publication Critical patent/SI1941026T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Pyridine Compounds (AREA)

SI200631796T 2005-10-24 2006-10-24 Postopki za proizvodnjo beljakovin z uporabo protisenescenčnih spojin SI1941026T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US72957305P	2005-10-24	2005-10-24
PCT/US2006/041256 WO2007050498A2 (en)	2005-10-24	2006-10-24	Methods of protein production using anti-senescence compounds
EP06844211.0A EP1941026B1 (en)	2005-10-24	2006-10-24	Methods of protein production using anti-senescence compounds

Publications (1)

Publication Number	Publication Date
SI1941026T1 true SI1941026T1 (sl)	2014-07-31

Family

ID=37873105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200631796T SI1941026T1 (sl)	2005-10-24	2006-10-24	Postopki za proizvodnjo beljakovin z uporabo protisenescenčnih spojin

Country Status (24)

Country	Link
US (1)	US20070110743A1 (sl)
EP (1)	EP1941026B1 (sl)
JP (2)	JP2009512459A (sl)
KR (1)	KR101402634B1 (sl)
CN (1)	CN101297027B (sl)
AR (1)	AR058140A1 (sl)
AU (1)	AU2006306433B2 (sl)
BR (1)	BRPI0617744A2 (sl)
CA (1)	CA2627003C (sl)
CR (1)	CR9897A (sl)
DK (1)	DK1941026T3 (sl)
EC (1)	ECSP088395A (sl)
ES (1)	ES2485374T3 (sl)
HK (1)	HK1120552A1 (sl)
IL (1)	IL190550A (sl)
NI (1)	NI200800111A (sl)
NO (1)	NO20081622L (sl)
PE (1)	PE20070796A1 (sl)
PL (1)	PL1941026T3 (sl)
PT (1)	PT1941026E (sl)
RU (1)	RU2491347C2 (sl)
SI (1)	SI1941026T1 (sl)
TW (1)	TW200736397A (sl)
WO (1)	WO2007050498A2 (sl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2440487T3 (es)	2006-07-13	2014-01-29	Wyeth Llc	Producción de glucoproteínas
AU2007294731B2 (en)	2006-09-13	2014-04-17	Abbvie Inc.	Cell culture improvements
US8911964B2 (en)	2006-09-13	2014-12-16	Abbvie Inc.	Fed-batch method of making human anti-TNF-alpha antibody
TW200902708A (en) *	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
TW201024318A (en)	2008-10-20	2010-07-01	Abbott Lab	Isolation and purification of antibodies using protein A affinity chromatography
SG195577A1 (en)	2008-10-20	2013-12-30	Abbott Lab	Viral inactivation during purification of antibodies
WO2011018472A2 (en)	2009-08-14	2011-02-17	Basf Se	Methods in cell cultures, and related inventions, employing certain additives
SG187198A1 (en)	2010-08-05	2013-03-28	Amgen Inc	Dipeptides to enhance yield and viability from cell cultures
US20130224855A1 (en) *	2010-08-31	2013-08-29	Abhishek Gupta	Culture medium for eukaryotic cells
EP2702077A2 (en)	2011-04-27	2014-03-05	AbbVie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
TW201247874A (en) *	2011-05-25	2012-12-01	United Biomedical Inc	Method for producing the activity of bone activating protein
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
WO2013158273A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Methods to modulate c-terminal lysine variant distribution
US9505833B2 (en)	2012-04-20	2016-11-29	Abbvie Inc.	Human antibodies that bind human TNF-alpha and methods of preparing the same
US9334319B2 (en)	2012-04-20	2016-05-10	Abbvie Inc.	Low acidic species compositions
US9249182B2 (en)	2012-05-24	2016-02-02	Abbvie, Inc.	Purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
WO2014035475A1 (en)	2012-09-02	2014-03-06	Abbvie Inc.	Methods to control protein heterogeneity
AU2014229557B2 (en) *	2013-03-13	2017-12-07	Anteis Sa	Peptides for skin rejuvenation and methods of using the same
US8921526B2 (en)	2013-03-14	2014-12-30	Abbvie, Inc.	Mutated anti-TNFα antibodies and methods of their use
US9499614B2 (en)	2013-03-14	2016-11-22	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
EP2970875B1 (en) *	2013-03-15	2020-04-15	F.Hoffmann-La Roche Ag	Cell culture compositions with antioxidants and methods for polypeptide production
US9598667B2 (en)	2013-10-04	2017-03-21	Abbvie Inc.	Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
CA2926588C (en)	2013-10-16	2020-07-21	Oncobiologics, Inc.	Buffer formulations for enhanced antibody stability
US8946395B1 (en)	2013-10-18	2015-02-03	Abbvie Inc.	Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
CN104398398A (zh) *	2014-10-27	2015-03-11	陈少威	一种细胞量子动力素(平衡剂)及其使用方法
MA40864A (fr) *	2014-10-31	2017-09-05	Biogen Ma Inc	Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères
EP3247718B1 (en)	2015-01-21	2021-09-01	Outlook Therapeutics, Inc.	Modulation of charge variants in a monoclonal antibody composition
TW202440904A (zh)	2015-08-04	2024-10-16	美商再生元醫藥公司	補充牛磺酸之細胞培養基及用法（二）
CN108350416A (zh)	2015-11-09	2018-07-31	百时美施贵宝公司	操纵在cho细胞中产生的多肽的品质属性的方法
CN109153717A (zh) *	2016-01-06	2019-01-04	安口生物公司	减少单克隆抗体组合物中的高分子量物类、酸性电荷物类和片段
JP7084308B2 (ja)	2016-02-03	2022-06-14	アウトルックセラピューティクス，インコーポレイティド	抗体安定性を増大させるための緩衝液製剤
MX2020003555A (es) *	2017-10-16	2020-08-03	Regeneron Pharma	Sistemas de espectroscopia raman in situ y metodos para controlar variables de proceso en cultivos celulares.
WO2025053166A1 (ja) *	2023-09-05	2025-03-13	味の素株式会社	培地組成物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8308235D0 (en) *	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en) *	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US5225539A (en) *	1986-03-27	1993-07-06	Medical Research Council	Recombinant altered antibodies and methods of making altered antibodies
US5223409A (en) *	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
US5530101A (en) *	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
EP0417563B1 (de) *	1989-09-12	2000-07-05	F. Hoffmann-La Roche Ag	TNF-bindende Proteine
US5859205A (en) *	1989-12-21	1999-01-12	Celltech Limited	Humanised antibodies
WO1992009298A1 (en)	1990-11-23	1992-06-11	Peptide Technology Ltd.	The delay, prevention and/or reversal of cell senescence
DE122004000008I1 (de) *	1991-06-14	2005-06-09	Genentech Inc	Humanisierter Heregulin Antikörper.
RU2245365C2 (ru) *	1994-01-03	2005-01-27	Генентек Инк.	Тромбопоэтин
US5830761A (en) *	1995-06-07	1998-11-03	Genetics Institute, Inc.	Medium and methods for culturing mammalian cho cells
RU2134120C1 (ru) *	1995-06-26	1999-08-10	Безруков Михаил Васильевич	Средство для стабилизации пептидной связи в белковом препарате
PT859841E (pt) *	1995-08-18	2002-11-29	Morphosys Ag	Bibliotecas de proteinas/ (poli) peptidos
JP4306813B2 (ja) *	1995-09-19	2009-08-05	アスビオファーマ株式会社	動物細胞の新規培養方法
US6146847A (en) *	1996-11-01	2000-11-14	Genespan Corporation	Stabilized transient gene expression
JP4215172B2 (ja) *	1996-12-03	2009-01-28	アムジェンフレモントインク．	複数のＶ▲下Ｈ▼およびＶ▲下κ▼領域を含むヒトＩｇ遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体
US20030040095A1 (en) *	2001-03-16	2003-02-27	Achille Arini	Method for the production of pharmaceutically active recombinant proteins
WO2002086101A2 (en) *	2001-04-24	2002-10-31	Innogenetics N.V.	Core-glycosylated hcv envelope proteins
EP1575998A4 (en) *	2002-12-23	2007-07-25	Bristol Myers Squibb Co	PROCESS FOR CULTIVATING MAMMALIAN CELLS FOR PROTEIN PRODUCTION
BRPI0415887B1 (pt) *	2003-10-27	2021-01-26	Wyeth	métodos para a remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatita
WO2005064013A1 (en)	2003-12-23	2005-07-14	Bart Janssen	The use of carnosine metabolism-associated genes to determine genetic predisposition/susceptibility to diabetic nephropathy
US7335491B2 (en) *	2004-08-27	2008-02-26	Wyeth Research Ireland Limited	Production of anti-abeta
TWI364458B (en) *	2004-08-27	2012-05-21	Wyeth Res Ireland Ltd	Production of tnfr-lg
US7294484B2 (en) *	2004-08-27	2007-11-13	Wyeth Research Ireland Limited	Production of polypeptides
US7426440B2 (en) *	2004-09-24	2008-09-16	Nutritional Bioscience Ltd.	Repair and protection factor scoring method for bioactive agents

2006
- 2006-10-23 AR ARP060104624A patent/AR058140A1/es unknown
- 2006-10-23 PE PE2006001284A patent/PE20070796A1/es not_active Application Discontinuation
- 2006-10-24 PL PL06844211T patent/PL1941026T3/pl unknown
- 2006-10-24 TW TW095139179A patent/TW200736397A/zh unknown
- 2006-10-24 US US11/585,607 patent/US20070110743A1/en not_active Abandoned
- 2006-10-24 AU AU2006306433A patent/AU2006306433B2/en active Active
- 2006-10-24 WO PCT/US2006/041256 patent/WO2007050498A2/en active Application Filing
- 2006-10-24 SI SI200631796T patent/SI1941026T1/sl unknown
- 2006-10-24 CN CN2006800396267A patent/CN101297027B/zh active Active
- 2006-10-24 RU RU2008113220/10A patent/RU2491347C2/ru active
- 2006-10-24 PT PT68442110T patent/PT1941026E/pt unknown
- 2006-10-24 BR BRPI0617744-1A patent/BRPI0617744A2/pt not_active Application Discontinuation
- 2006-10-24 JP JP2008537834A patent/JP2009512459A/ja not_active Withdrawn
- 2006-10-24 DK DK06844211.0T patent/DK1941026T3/da active
- 2006-10-24 KR KR1020087009856A patent/KR101402634B1/ko not_active Expired - Fee Related
- 2006-10-24 CA CA2627003A patent/CA2627003C/en active Active
- 2006-10-24 ES ES06844211.0T patent/ES2485374T3/es active Active
- 2006-10-24 EP EP06844211.0A patent/EP1941026B1/en active Active
2008
- 2008-04-01 IL IL190550A patent/IL190550A/en active IP Right Grant
- 2008-04-02 NO NO20081622A patent/NO20081622L/no not_active Application Discontinuation
- 2008-04-09 NI NI200800111A patent/NI200800111A/es unknown
- 2008-04-18 CR CR9897A patent/CR9897A/es not_active Application Discontinuation
- 2008-04-23 EC EC2008008395A patent/ECSP088395A/es unknown
- 2008-12-03 HK HK08113179.8A patent/HK1120552A1/xx unknown
2013
- 2013-04-26 JP JP2013094315A patent/JP5907928B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2485374T3 (es)	2014-08-13
CR9897A (es)	2008-07-29
CN101297027B (zh)	2013-04-03
AU2006306433A1 (en)	2007-05-03
BRPI0617744A2 (pt)	2011-08-02
JP2013165728A (ja)	2013-08-29
US20070110743A1 (en)	2007-05-17
KR20080063365A (ko)	2008-07-03
AU2006306433B2 (en)	2013-04-18
TW200736397A (en)	2007-10-01
RU2008113220A (ru)	2009-12-10
WO2007050498A3 (en)	2007-07-12
RU2491347C2 (ru)	2013-08-27
NO20081622L (no)	2008-06-18
CN101297027A (zh)	2008-10-29
IL190550A0 (en)	2008-11-03
PE20070796A1 (es)	2007-08-15
EP1941026A2 (en)	2008-07-09
ECSP088395A (es)	2008-05-30
DK1941026T3 (da)	2014-07-21
WO2007050498A2 (en)	2007-05-03
NI200800111A (es)	2009-03-03
HK1120552A1 (en)	2009-04-03
KR101402634B1 (ko)	2014-06-03
CA2627003C (en)	2018-08-28
PT1941026E (pt)	2014-07-31
JP5907928B2 (ja)	2016-04-26
PL1941026T3 (pl)	2014-12-31
EP1941026B1 (en)	2014-06-04
CA2627003A1 (en)	2007-05-03
JP2009512459A (ja)	2009-03-26
AR058140A1 (es)	2008-01-23
IL190550A (en)	2017-01-31

Publication	Publication Date	Title
IL190550A0 (en)	2008-11-03	Methods of protein production using anti-senescence compounds
IL201719A0 (en)	2011-08-01	Methods of protein production using anti-senescence compounds
HK1124488A1 (en)	2009-07-17	Production of canola protein
ZA200711016B (en)	2008-09-25	Method for production of 1-alkyl-3-phenyluracils
ZA200805297B (en)	2009-05-27	Method of using ß-hydroxy-ß-methylbutyrate
IL181587A0 (en)	2007-07-04	Production of ??-abeta
GB0823478D0 (en)	2009-01-28	Method of cementing
IL184851A0 (en)	2007-12-03	Process of producing olefins
IL185757A0 (en)	2008-01-06	Methods of decreasing calcifcation
EP1869192A4 (en)	2010-10-20	FRAME MIXTURE OF ANTIBODIES
ZA200804264B (en)	2009-01-28	Process for the preparation of ferri-succinylcasein
ZA200601910B (en)	2006-11-29	Process for the preparation of organosilances
GB0426160D0 (en)	2004-12-29	Production of proteins
IL184715A0 (en)	2007-12-03	Process for the preparation of intermediates
EP1964538A4 (en)	2013-04-10	PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES
IL183106A0 (en)	2007-09-20	Production of proteins
IL187155A0 (en)	2008-02-09	Process for production of 4-biphenylazetidin-2-ones
EP1917231A4 (en)	2008-11-12	PROCESS FOR THE PRODUCTION OF BROMOPICRIN
PL1912961T3 (pl)	2013-04-30	Sposób wytwarzania bepromoliny
ZA200710066B (en)	2008-09-25	Process for production of 4-biphenylylazetidin-2-ones
IL182134A0 (en)	2007-07-24	Process for production of 2-chloro-4-nitroimidazole
IL177448A0 (en)	2007-07-04	Methods for protein production
IL189687A0 (en)	2008-06-05	Process of preparing bromopicrin
GB0509343D0 (en)	2005-06-15	Biological production of canthaxanthin
PL377916A1 (pl)	2006-05-02	Sposób wytwarzania optycznie czystego R-(–)-1-okten-3-olu